A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.
about
Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive ReviewAbuse and Misuse of Pregabalin and Gabapentin.Law enforcement-derived data on gabapentin diversion and misuse, 2002-2015: diversion rates and qualitative research findings.Review about gabapentin misuse, interactions, contraindications and side effects.Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials.Providing chronic pain management in the "Fifth Vital Sign" Era: Historical and treatment perspectives on a modern-day medical dilemma.Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population.Early signal of diverted use of tropicamide eye drops in France.Intentional Drug Overdose Involving Pregabalin and Gabapentin: Findings from the National Self-Harm Registry Ireland, 2007-2015.Gabapentin for the treatment of alcohol use disorder.Medications for substance use disorders (SUD): emerging approaches.Addiction-related interactions of pregabalin with morphine in mice and humans: reinforcing and inhibiting effects.Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.Is There a Potential of Misuse for Venlafaxine and Bupropion?Effectiveness of fixed-site high-frequency transcutaneous electrical nerve stimulation in chronic pain: a large-scale, observational study.Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis.Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance
P2860
Q28074617-15DB4ACE-E4AC-4425-90CE-A785D647F142Q30238678-7DF0291F-E908-45B1-9AEB-79918C4731C1Q36368798-E7FE73F6-7E70-4C80-B19E-311C630909A3Q37641479-8A26CD23-8D4D-4EED-84C2-216CB23680B5Q38623830-319D4BD1-E4BF-4F31-8506-3519FF52B866Q38737065-FDECED56-C757-47E4-8F00-EF373093151CQ38815468-BDD0B4EE-A47C-4C8F-BBF9-E9CA01107B11Q38940500-57ADDDA1-E8DA-441E-92C9-54F4E30CD779Q47271510-DF2897D4-FA49-4E3F-913A-6D617816935CQ47309377-7F040644-0D64-4993-B6A9-D595D53B1AC0Q47731975-00B14FE8-FDA9-46DE-B2FD-50E748A347B7Q48351988-03EC8D79-5AB0-432C-8583-2641EAFB4E2FQ52318376-D65E381C-820B-4109-AD33-E48DA43CD5FAQ52606203-EA895160-FC92-4D5E-AF95-8E9D9861143DQ55135338-BB9A6BEC-004A-48EB-8819-06CAAF05DA14Q55456112-2D5998B3-B2FC-4B26-B97D-8A0399744C64Q58770131-86B5C614-4BE3-42F5-8885-CE1403997255
P2860
A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Decade of Gabapentinoid Misu ...... erse Drug Reactions' Database.
@en
A Decade of Gabapentinoid Misu ...... erse Drug Reactions' Database.
@nl
type
label
A Decade of Gabapentinoid Misu ...... erse Drug Reactions' Database.
@en
A Decade of Gabapentinoid Misu ...... erse Drug Reactions' Database.
@nl
prefLabel
A Decade of Gabapentinoid Misu ...... erse Drug Reactions' Database.
@en
A Decade of Gabapentinoid Misu ...... erse Drug Reactions' Database.
@nl
P2860
P1433
P1476
A Decade of Gabapentinoid Misu ...... erse Drug Reactions' Database.
@en
P2093
Fabrizio Schifano
Stefania Chiappini
P2860
P2888
P304
P356
10.1007/S40263-016-0359-Y
P577
2016-06-16T00:00:00Z